SUPERFICIAL SPREADING MELANOMA STAGE UNSPECIFIED

SUPERFICIAL SPREADING MELANOMA STAGE UNSPECIFIED was reported 254 times

SUPERFICIAL SPREADING MELANOMA STAGE UNSPECIFIED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Sphingosine 1-phosphate Receptor Modulator [EPC] 10 0.0007
1 Interleukin-17A Antagonist [EPC] 12 0.0003
2 Vitamin D Analog [EPC] 5 0.0003
3 Nonergot Dopamine Agonist [EPC] 3 0.0002
4 Provitamin D2 Compound [EPC] 5 0.0002
5 Recombinant Human Growth Hormone [EPC] 3 0.0001
6 Cephalosporin Antibacterial [EPC] 1 0.0001
7 Purine Antimetabolite [EPC] 11 0.0001
8 Androgen [EPC] 3 0.0001
9 CD19-directed Chimeric Antigen Receptor [EPC] 1 0.0001
10 Proteasome Inhibitor [EPC] 11 0.0001
11 Interleukin-23 Antagonist [EPC] 10 0.0001
12 Integrin Receptor Antagonist [EPC] 8 0.0001
13 Serotonin Reuptake Inhibitor [EPC] 8 0.0001
14 Bile Acid Sequestrant [EPC] 1 0.0001
15 Stimulant Laxative [EPC] 1 0.0001
16 Calcineurin Inhibitor Immunosuppressant [EPC] 9 0.0001
17 Interleukin-12 Antagonist [EPC] 7 0.0001
18 Pyrimidine Synthesis Inhibitor [EPC] 3 0.0001
19 Phosphodiesterase 5 Inhibitor [EPC] 9 0.0001
20 Programmed Death Receptor-1 Blocking Antibody [EPC] 6 0.0001
21 Folate Analog Metabolic Inhibitor [EPC] 24 0.0001
22 CD52-directed Cytolytic Antibody [EPC] 1 0.0001
23 Tumor Necrosis Factor Blocker [EPC] 47 0.0000
24 Bile Acid [EPC] 1 0.0000
25 Epidermal Growth Factor Receptor Antagonist [EPC] 2 0.0000
26 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
27 Antirheumatic Agent [EPC] 4 0.0000
28 Thalidomide Analog [EPC] 18 0.0000
29 Corticosteroid [EPC] 43 0.0000
30 Factor Xa Inhibitor [EPC] 8 0.0000
31 Kinase Inhibitor [EPC] 14 0.0000
32 Janus Kinase Inhibitor [EPC] 4 0.0000
33 Alkylating Drug [EPC] 6 0.0000
34 Muscle Relaxant [EPC] 1 0.0000
35 Interleukin-6 Receptor Antagonist [EPC] 3 0.0000
36 Vitamin C [EPC] 9 0.0000
37 Insulin [EPC] 1 0.0000
38 Selective T Cell Costimulation Modulator [EPC] 3 0.0000
39 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 2 0.0000
40 CTLA-4-directed Blocking Antibody [EPC] 1 0.0000
41 5-alpha Reductase Inhibitor [EPC] 2 0.0000
42 Azole Antifungal [EPC] 3 0.0000
43 Macrolide Antimicrobial [EPC] 1 0.0000
44 Aromatase Inhibitor [EPC] 2 0.0000
45 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1 0.0000
46 Vitamin D [EPC] 5 0.0000
47 Sulfonylurea [EPC] 2 0.0000
48 CD20-directed Cytolytic Antibody [EPC] 5 0.0000
49 Angiotensin 2 Receptor Blocker [EPC] 5 0.0000
50 Fluoroquinolone Antibacterial [EPC] 2 0.0000
51 Vitamin B12 [EPC] 5 0.0000
52 Proton Pump Inhibitor [EPC] 9 0.0000
53 Dihydropyridine Calcium Channel Blocker [EPC] 5 0.0000
54 Nitroimidazole Antimicrobial [EPC] 1 0.0000
55 RANK Ligand Inhibitor [EPC] 3 0.0000
56 Expectorant [EPC] 3 0.0000
57 Tetracycline-class Drug [EPC] 1 0.0000
58 Androgen Receptor Inhibitor [EPC] 1 0.0000
59 Topoisomerase Inhibitor [EPC] 1 0.0000
60 Retinoid [EPC] 3 0.0000
61 Nonsteroidal Anti-inflammatory Drug [EPC] 15 0.0000
62 Opioid Agonist [EPC] 3 0.0000
63 HMG-CoA Reductase Inhibitor [EPC] 4 0.0000
64 Aminosalicylate [EPC] 1 0.0000
65 Platelet Aggregation Inhibitor [EPC] 5 0.0000
66 Loop Diuretic [EPC] 4 0.0000
67 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
68 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
69 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
70 Osmotic Laxative [EPC] 2 0.0000
71 Calcium [EPC] 1 0.0000
72 Insulin Analog [EPC] 3 0.0000
73 Aldosterone Antagonist [EPC] 1 0.0000
74 Interferon beta [EPC] 1 0.0000
75 Thiazide Diuretic [EPC] 1 0.0000
76 Benzodiazepine [EPC] 3 0.0000
77 Atypical Antipsychotic [EPC] 1 0.0000
78 Interleukin-4 Receptor alpha Antagonist [EPC] 1 0.0000